TYG-200

N/A

Report date: 2022/03/03 17:34:05

Base Information

Drug NameTYG-200
Drug Alias Name靶向HER2/neu受体疫苗(优锐医药)TYG200OQR200OQR-200
ClassificationVaccines
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOncoQR ML GmbHTYG Oncology Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A